p21 (Waf1/Cip1) and FasL gene activation via Sp1 and NFκB is required for leukemia cell survival but not for cell death induced by diverse stimuli
- 30 April 2005
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 37 (4) , 784-796
- https://doi.org/10.1016/j.biocel.2004.10.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Regulation of the activity of Sp1-related transcription factorsMolecular and Cellular Endocrinology, 2002
- The promise of retinoids to fight against cancerNature Reviews Cancer, 2001
- Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAILNature Medicine, 2001
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrestOncogene, 1999
- Expression and function of CD95 (FAS/APO‐1) in leukaemia‐lymphoma tumour linesBritish Journal of Haematology, 1997
- The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic CellsPublished by Elsevier ,1996
- Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytesBiochemical Pharmacology, 1994
- Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cellsCell, 1989
- The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expressionBlood, 1987